Herbas VPB

Print
EN | LT
LT - COMBINATION OF A PD-1 ANTAGONIST AND A 4-1BB AGONIST FOR TREATING CANCER
EN - COMBINATION OF A PD-1 ANTAGONIST AND A 4-1BB AGONIST FOR TREATING CANCER

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28
A61P 35/00
A61K 39/35
European patent
(11) Number of the document 3102604
(13) Kind of document T
(96) European patent application number 15703438.0
Date of filing the European patent application 2015-02-03
(97) Date of publication of the European application 2016-12-14
(45) Date of publication and mention of the grant of the patent 2020-01-15
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2015/014199
Date 2015-02-03
PCT application publication
(87) Number WO 2015/119923
Date 2015-08-13
Priority applications
(30) Number Date Country code
201461935748 P 2014-02-04 US
Inventors
(72)
DAVIS, Craig, Bennett, US
KOEHLER, Maria, Theresa, US
YAN, Li, US
Grantee
(73) Pfizer Inc., 235 East 42nd Street, New York, NY 10017, US
Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065, US
Title
(54) COMBINATION OF A PD-1 ANTAGONIST AND A 4-1BB AGONIST FOR TREATING CANCER
  COMBINATION OF A PD-1 ANTAGONIST AND A 4-1BB AGONIST FOR TREATING CANCER
Last update date 2021-04-30